Potential treatment for multiple system atrophy shows promise
Category: News
New immunotherapy offers hope for recurrent cervical cancer
Treatment expands options for HER2-negative metastatic breast cancer
New methodology may boost innovation in protein engineering
CSL Behring’s study reveals significant long-term benefits
Partnership aims to leverage cutting-edge technology in clinical trials
Designation follows promising preclinical data and FDA clearance
Breast cancer therapy offers hope for patients at risk of recurrence
Partnership aims to create recombinant nanobodies to treat immune disorders